Citadel Advisors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Citadel Advisors’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,500	Closed	-$1.86K	–	15750
2025 Q1	$1.86K	Buy	34,500 +32,500	+1,625%	+$7.76K	﹤0.01%	14090
2024 Q4	$1.11K	Sell	2,000 -68,900	-97%	-$54.3K	﹤0.01%	14222
2024 Q3	$69.5K	Sell	70,900 -34,400	-33%	-$36.8K	﹤0.01%	11570
2024 Q2	$128K	Sell	105,300 -50,600	-32%	-$86.3K	﹤0.01%	10560
2024 Q1	$590K	Buy	+155,900	New	+$293K	﹤0.01%	8016

Other funds holding OCEA

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

Citadel Advisors's OCEA Position: Q2 2025 in Review

Citadel Advisors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 473,098 shares — an estimated $25.5K sold.

Citadel Advisors first reported a position in OCEA in Q1 2024 and held it in 4 quarters. The position peaked at $32.3K in Q3 2024. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

Citadel Advisors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Citadel Advisors sold 473,098 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $25.5K.
Citadel Advisors first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
Citadel Advisors's Ocean Biomedical, Inc. Common Stock position peaked at $32.3K in Q3 2024.
7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.